Precision cancer diagnosis firm 3D Med Diagnosis has raised 280 million yuan ($40 million) to spruce up its R&D for its growing product pipeline. In a separate development, human resource SaaS provider eRoad Software has secured over $14 million from SIG and Hillhouse Capital, among others.
3D Med Diagnosis raises $40m
3D Medicines Corporation (3D Med), a precision cancer care medicine company, has announced that its affiliate 3D Med Diagnosis has secured 280 million yuan ($40 million) in its debut funding round after spinning off the division in 2018 to accelerate R&D of its product pipeline, per a company statement.
